Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study.

Pearce SHS, Dayan C, Wraith DC, Barrell K, Olive N, Jansson L, Walker-Smith T, Carnegie C, Martin KF, Boelaert K, Gilbert J, Higham CE, Muller I, Murray RD, Perros P, Razvi S, Vaidya B, Wernig F, Kahaly GJ.

Thyroid. 2019 Jul;29(7):1003-1011. doi: 10.1089/thy.2019.0036. Epub 2019 Jun 13.

PMID:
31194638
2.

Surface coatings including fingerprint residues can significantly alter the size and shape of bloodstains.

Shiri S, Martin KF, Bird JC.

Forensic Sci Int. 2019 Feb;295:189-198. doi: 10.1016/j.forsciint.2018.12.008. Epub 2018 Dec 19.

PMID:
30622046
3.

Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice.

Jansson L, Vrolix K, Jahraus A, Martin KF, Wraith DC.

Endocrinology. 2018 Sep 1;159(9):3446-3457. doi: 10.1210/en.2018-00306.

PMID:
30099489
4.

Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.

Streeter HB, Rigden R, Martin KF, Scolding NJ, Wraith DC.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 12;2(3):e93. doi: 10.1212/NXI.0000000000000093. eCollection 2015 Jun.

5.

Human exposure to rabid free-ranging cats: a continuing public health concern in Pennsylvania.

Campagnolo ER, Lind LR, Long JM, Moll ME, Rankin JT, Martin KF, Deasy MP, Dato VM, Ostroff SM.

Zoonoses Public Health. 2014 Aug;61(5):346-55. doi: 10.1111/zph.12077. Epub 2013 Oct 15.

PMID:
24134434
6.

Oral Hodgkin lymphoma: a wolf in wolf's clothing.

Whitt JC, Dunlap CL, Martin KF.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Nov;104(5):e45-51. Review.

PMID:
17964472
7.

KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders.

Smith SL, Heal DJ, Martin KF.

CNS Drug Rev. 2005 Summer;11(2):113-40. Review.

8.

An electrophysiological study of the effects of propofol on native neuronal ligand-gated ion channels.

Patten D, Foxon GR, Martin KF, Halliwell RF.

Clin Exp Pharmacol Physiol. 2001 May-Jun;28(5-6):451-8.

PMID:
11380521
10.

The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex.

Kettle CJ, Cheetham SC, Martin KF, Prow MR, Heal DJ.

Neuropharmacology. 1999 Sep;38(9):1421-30.

PMID:
10471096
11.
12.

A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents.

Heal DJ, Cheetham SC, Prow MR, Martin KF, Buckett WR.

Br J Pharmacol. 1998 Sep;125(2):301-8.

13.

Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.

Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC.

Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl 1:S18-28; discussion S29. Review.

PMID:
9758240
14.

GABA-evoked depolarisations in the rat cortical wedge: involvement of GABAA receptors and HCO3- ions.

Phillips I, Martin KF, Thompson KS, Heal DJ.

Brain Res. 1998 Jul 6;798(1-2):330-2.

PMID:
9666162
15.

Weak blockade of AMPA receptor-mediated depolarisations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepine.

Phillips I, Martin KF, Thompson KS, Heal DJ.

Eur J Pharmacol. 1997 Oct 22;337(2-3):189-95.

PMID:
9430413
16.
17.

In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.

Gundlah C, Martin KF, Heal DJ, Auerbach SB.

J Pharmacol Exp Ther. 1997 Nov;283(2):581-91.

PMID:
9353373
18.

The impact of scheduling patients for refills on the process of providing pharmaceutical care and prescription revenue.

Martin KF, Lewis RK.

Pharm Pract Manag Q. 1997 Jul;17(2):64-74. No abstract available.

PMID:
10168179
19.

8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation.

Prow MR, Martin KF, Heal DJ.

Eur J Pharmacol. 1996 Dec 12;317(1):21-8.

PMID:
8982715
20.
21.
22.

Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments.

Martin KF, Phillips I, Cheetham SC, Heal DJ.

Pharmacol Biochem Behav. 1995 Aug;51(4):565-9.

PMID:
7675827
23.
24.

Use of a check-off system to improve middle school students' story compositions.

Martin KF, Manno C.

J Learn Disabil. 1995 Mar;28(3):139-49.

PMID:
7699301
26.

Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors.

Luscombe GP, Martin KF, Hutchins LJ, Gosden J, Heal DJ.

Br J Pharmacol. 1993 Mar;108(3):669-77.

28.

The control of intracellular calcium and neurotransmitter release in guinea pig-derived cerebral cortical synaptoneurosomes.

Iredale PA, Martin KF, Hill SJ, Kendall DA.

Biochem Pharmacol. 1993 Jan 26;45(2):407-14.

PMID:
8094616
29.
30.

Qualitative differences in [Ca2+]i increases and InsP3 generation following stimulation of N1E-115 cells with micromolar and millimolar ATP.

Iredale PA, Martin KF, Alexander SP, Hill SJ, Kendall DA.

Biochem Pharmacol. 1992 Oct 20;44(8):1479-87.

PMID:
1417971
32.

Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol.

Iredale PA, Martin KF, Hill SJ, Kendall DA.

Eur J Pharmacol. 1992 Jun 5;226(2):163-8.

PMID:
1639111
33.

Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo.

Martin KF, Hannon S, Phillips I, Heal DJ.

Br J Pharmacol. 1992 May;106(1):139-42.

34.

Membrane stabilising properties of the selective 5-HT2 receptor agonist, (+/-)-DOI.

Martin KF, Kellett R, Buckett WR.

Eur J Pharmacol. 1991 Jul 23;200(1):191-3.

PMID:
1769371
35.

Histamine-induced changes in intracellular calcium in undifferentiated N1E-115 cells.

Iredale PA, Ruck A, Martin KF, Kendall DA, Hill SJ.

Biochem Soc Trans. 1991 Feb;19(1):6S. No abstract available.

PMID:
2037190
36.

Rhythms in neurotransmitter turnover: focus on the serotonergic system.

Martin KF.

Pharmacol Ther. 1991;51(3):421-9. Review.

PMID:
1686496
37.

Biochemical and in vivo voltammetric evidence for differences in striatal dopamine levels in inbred strains of mice.

Sanghera MK, Crespi F, Martin KF, Heal DJ, Buckett WR, Marsden CA.

Neuroscience. 1990;39(3):649-56.

PMID:
2097519
38.

Measurement of 3-methoxytyramine by in vivo voltammetry: evidence for differences in central dopamine function in BALB/c and CBA mice.

Crespi F, Martin KF, Heal DJ, Marsden CA, Buckett WR, Sanghera MK.

Brain Res. 1989 Oct 23;500(1-2):241-6.

PMID:
2605493
39.
40.

Functional identification of 5HT receptor subtypes.

Marsden CA, Sleight AJ, Fone KC, Jonson JV, Crespi F, Martin KF, Garrett JC, Bennett GW.

Comp Biochem Physiol A Comp Physiol. 1989;93(1):107-14. Review. No abstract available.

PMID:
2568213
43.
44.
45.

In vivo electrochemistry--principles and applications.

Martin KF, Marsden CA.

Life Sci. 1987 Aug 17;41(7):865-8.

PMID:
3613846
48.
49.

Application of intracerebral dialysis and in vivo voltammetry to pharmacological and physiological studies of amine neurotransmitters.

Marsden CA, Martin KF, Routledge C, Brazell MP, Maidment NT.

Ann N Y Acad Sci. 1986;473:106-25. No abstract available.

PMID:
2432817
50.

Supplemental Content

Loading ...
Support Center